Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Persimmon PLC

Consumer Cyclical GB PSN

1069.0GBX
-1.0(0.09%)

Last update at 2026-06-03T15:35:00Z

Day Range

1060.401077.50
LowHigh

52 Week Range

1013.141552.00
LowHigh

Fundamentals

  • Previous Close 1070.00
  • Market Cap3693.14M
  • Volume669669
  • P/E Ratio13.09
  • Dividend Yield5.11%
  • EBITDA479.90M
  • Revenue TTM3751.30M
  • Revenue Per Share TTM11.72
  • Gross Profit TTM 656.30M
  • Diluted EPS TTM0.88

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 397.30M 359.10M 351.80M 730.70M 966.80M
Minority interest - - - - -
Net income 285.70M 267.10M 255.40M 561.00M 787.20M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit 576.70M 580.40M 795.10M 867.50M 1083.80M
Reconciled depreciation 21.20M 20.10M 18.70M 15.80M 14.50M
Ebit 416.10M 372.90M 366.60M 734.80M 970.40M
Ebitda 437.20M 393.00M 385.30M 750.60M 984.90M
Depreciation and amortization 21.10M 20.10M 18.70M 15.80M 14.50M
Non operating income net other - - - - -
Operating income 416.10M 394.20M 346.90M 734.80M 970.40M
Other operating expenses 3335.20M 2806.50M 2426.30M 3090.90M 2650.00M
Interest expense 30.90M 13.80M 13.20M 4.10M 3.60M
Tax provision 111.60M 92.00M 96.40M 169.70M 179.60M
Interest income 11.40M 9.60M 18.10M 6.00M 9.90M
Net interest income -26.50000M -10.10000M 4.90M 5.80M 6.30M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 111.60M 92.00M 96.40M 169.70M 179.60M
Total revenue 3751.30M 3200.70M 2773.20M 3815.80M 3610.50M
Total operating expenses 160.60M 186.20M 448.20M 142.60M 123.30M
Cost of revenue 3174.60M 2620.30M 1978.10M 2948.30M 2526.70M
Total other income expense net -18.80000M -35.10000M 4.90M -4.10000M -3.60000M
Discontinued operations - - - - -
Net income from continuing ops 285.70M 267.10M 255.40M 561.00M 787.20M
Net income applicable to common shares - - - 561.00M 787.20M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-06-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-06-30 2022-12-31
Total assets 5318.20M 4833.40M 4787.80M - 5034.10M
Intangible assets 71.50M 60.80M 60.00M - 60.00M
Earning assets - - - - -
Other current assets - 15.80M 27.90M - 221.90M
Total liab 1704.10M 1326.80M 1369.30M - 1594.80M
Total stockholder equity 3614.10M 3506.60M 3418.50M - 3439.30M
Deferred long term liab - - - - -
Other current liab 83.20M 398.50M 635.90M - 142.10M
Common stock 32.10M 32.00M 31.90M - 31.90M
Capital stock 32.10M 32.00M 31.90M - 31.90M
Retained earnings 3040.70M 2935.70M 2847.70M - 2868.50M
Other liab - - - - 492.40M
Good will 111.00M 103.80M 105.40M - 113.00M
Other assets - - - - 195.80M
Cash 117.00M 258.60M 420.10M - 861.60M
Cash and equivalents - - - - -
Total current liabilities 1218.00M 923.30M 948.90M - 1091.50M
Current deferred revenue - - 0.10M - -
Net debt -100.20000M 195.00M -420.10000M - -861.60000M
Short term debt 11.00M 247.10M -0.10000M - -
Short long term debt - - - - -
Short long term debt total 16.80M 453.60M 392.70M - -
Other stockholder equity 28.00M 25.60M 25.60M - 538.90M
Property plant equipment - - - - 118.60M
Total current assets 4863.80M 4348.30M 4308.20M - 4546.40M
Long term investments - - - - -
Net tangible assets - - - - 3266.30M
Short term investments - - 34.10M - -
Net receivables 254.50M 186.90M 159.00M - 153.70M
Long term debt - - - - -
Inventory 4492.30M 3902.80M 3701.20M - 3462.90M
Accounts payable 1123.80M 277.70M 312.80M - 949.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 513.30M 513.30M 513.30M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 130.70M 130.70M 161.20M - 185.60M
Deferred long term asset charges - - - - -
Non current assets total 454.40M 485.10M 479.60M - 487.70M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -45.00000M -42.90000M -29.80000M 1.80M
Change to liabilities - - - 141.10M 37.40M
Total cashflows from investing activities 26.80M -45.00000M -42.90000M -29.80000M -18.20000M
Net borrowings - - - -3.30000M -3.30000M
Total cash from financing activities -197.00000M -201.40000M -268.80000M -757.50000M -754.10000M
Change to operating activities - - - 13.30M 18.90M
Net income 285.70M 267.10M 255.40M 561.00M 787.20M
Change in cash -141.60000M -161.50000M -441.50000M -385.00000M 12.50M
Begin period cash flow 258.60M 420.10M 861.60M 1246.60M 1234.10M
End period cash flow 117.00M 258.60M 420.10M 861.60M 1246.60M
Total cash from operating activities 28.60M 84.90M -129.80000M 402.30M 784.80M
Issuance of capital stock 2.50M 0.10M 0.00000M 0.70M 2.60M
Depreciation 21.10M 20.10M 18.70M 15.80M 14.50M
Other cashflows from investing activities - -12.70000M -5.80000M - -
Dividends paid 192.10M 191.80M 255.40M 750.10M 749.60M
Change to inventory -590.10000M -200.40000M -235.30000M -532.50000M -9.80000M
Change to account receivables -84.70000M 17.30M 37.50M -81.10000M -59.50000M
Sale purchase of stock -2.30000M -0.20000M -1.20000M -0.70000M -
Other cashflows from financing activities -5.10000M -4.90000M -12.20000M -7.40000M -7.10000M
Change to netincome - - - 284.70M -3.90000M
Capital expenditures 40.60M 32.30M 36.40M 30.50M 20.90M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -349.40000M -232.70000M -425.70000M -459.20000M -13.00000M
Stock based compensation 16.10M 14.70M 4.50M 9.00M 6.40M
Other non cash items 68.40M 15.70M 14.90M 275.70M -8.10000M
Free cash flow -12.00000M 52.60M -166.20000M 371.80M 763.90M

Peer Comparison

Sector: Consumer Cyclical Industry: Residential Construction

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PSN
Persimmon PLC		 -1.0 0.09% 1069.00 13.09 11.36 0.98 1.04 0.97 8.01
BTRW
Barratt Redrow plc		 1.30 0.51% 258.10 17.48 7.42 0.62 0.47 0.60 8.14
BKG
The Berkeley Group Holdings plc		 14.00 0.41% 3398.00 9.33 9.23 1.35 0.83 1.11 4.89
TW
Taylor Wimpey PLC		 0.02 0.03% 76.32 29.22 11.40 0.80 0.71 0.70 13.13
BWY
Bellway PLC		 -14.0 0.77% 1801.00 15.61 9.03 0.83 0.63 0.80 8.70

Reports Covered

Stock Research & News

View All

Profile

Persimmon Plc, together with its subsidiaries, operates as a house builder in the United Kingdom. The company offers family housing under the Persimmon Homes brand name; housing under the Charles Church brand name; and social housing under the Westbury Partnerships brand name. It also provides broadband services under the FibreNest brand; and timber frame, insulated wall panels, and roof cassettes under the Space4 brand. In addition, the company offers concrete bricks under the Brickworks brand; and concrete roof tile under the Tileworks brand. Persimmon Plc was founded in 1972 and is headquartered in York, the United Kingdom.

Persimmon PLC

Persimmon House, York, United Kingdom, YO19 4FE

Key Executives

Name Title Year Born
Mr. John Stephen West Co-Founder, CEO, Pres & Director 1957
Mr. Aaron L. Tachibana Sr. VP & CFO 1961
Dr. Richard Chen M.D., M.S., MS Sr. VP of R&D and Chief Medical Officer 1971
Dr. Russ B. Altman M.D., Ph.D. Co-Founder and Member of Clinical & Scientific Advisory Board NA
Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D. Co-Founder and Member of Clinical & Scientific Advisory Board 1972
Dr. Atul Butte Co-Founder and Member of Clinical & Scientific Advisory Board NA
Dr. Michael Snyder Ph.D. Co-Founder and Member of Clinical & Scientific Advisory Board NA
Ms. Carol J. Tillis VP of Fin. & Admin. NA
Mr. Stephen M. Moore J.D. VP, Gen. Counsel & Corp. Sec. 1972
Mr. Michael J Fitzpatrick VP of Worldwide Sales NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.